TrueBlue Rg
TBI
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
12/27/2024 - 16:15:00
Bid
12/27/2024 - 16:00:00
Bid
Volume
Ask
12/27/2024 - 16:00:00
Ask
Volume
7.87
-0.30 ( -3.67% )
7.87
2,300
7.88
2,400
More information
Analysis by TheScreener
24.12.2024
Evaluation Negativ  
Interest Weak  
Sensibility High  
Analysis date: 24.12.2024
Global Evaluation
  Negativ
The stock is classified in the negative zone since 17.12.2024.
Interest
  Weak
Weak interest since 10.12.2024.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 06.08.2024 at a price of 8.10.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 03.12.2024), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 7.802.
4wk Rel Perf
  9.34%
 
The four week relative overperformance versus SP500 is 9.34%.
Sensibility
  High
The stock has been on the high-sensitivity level since 06.08.2024.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 1.16%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.62%.
Mkt Cap in $bn
  0.24
With a market capitalization <$2bn, TRUEBLUE is considered a small-cap stock.
G/PE Ratio
  0.14
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
  -56.53
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  7.83%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
  4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  95
For 1% of index variation, the stock varies on average by 0.95%.
Correlation
  0.27
Stock movements are strongly independent of index variations.
Value at Risk
  3.33
The value at risk is estimated at USD 3.33. The risk is therefore 41.69%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002